中国临床新医学
中國臨床新醫學
중국림상신의학
Chinese Journal of New Clinical Medicine
2015年
9期
833-835
,共3页
绝经后妇女%卵巢肿瘤%超声诊断
絕經後婦女%卵巢腫瘤%超聲診斷
절경후부녀%란소종류%초성진단
Postmenopausal women%Ovarian neoplasm%Ultrasonic diagnosis
目的:分析超声对绝经后妇女卵巢肿瘤的诊断价值。方法回顾性分析2011-10~2014-10来该院就诊的56例绝经后卵巢肿瘤患者的超声诊断资料。结果56例患者中71.4%(40/56)为良性肿瘤,28.6%(16/56)为恶性肿瘤。良性组以囊性为主,显著高于恶性组( P<0.01);在囊实性方面两者差异无统计学意义(P>0.05);在形态不规则、实性、壁结构异常、内部血流、腹水和阻力指数(RI)(<0.43)等指标声像图上恶性组均高于良性组,且差异具有统计学意义(均P<0.05)。超声诊断卵巢肿瘤的符合率为92.86%,灵敏度为97.37%,特异度为83.33%。结论超声能够快速、有效地鉴别出绝经后妇女卵巢肿瘤的性质,应当作为卵巢肿瘤临床首选筛查手段。
目的:分析超聲對絕經後婦女卵巢腫瘤的診斷價值。方法迴顧性分析2011-10~2014-10來該院就診的56例絕經後卵巢腫瘤患者的超聲診斷資料。結果56例患者中71.4%(40/56)為良性腫瘤,28.6%(16/56)為噁性腫瘤。良性組以囊性為主,顯著高于噁性組( P<0.01);在囊實性方麵兩者差異無統計學意義(P>0.05);在形態不規則、實性、壁結構異常、內部血流、腹水和阻力指數(RI)(<0.43)等指標聲像圖上噁性組均高于良性組,且差異具有統計學意義(均P<0.05)。超聲診斷卵巢腫瘤的符閤率為92.86%,靈敏度為97.37%,特異度為83.33%。結論超聲能夠快速、有效地鑒彆齣絕經後婦女卵巢腫瘤的性質,應噹作為卵巢腫瘤臨床首選篩查手段。
목적:분석초성대절경후부녀란소종류적진단개치。방법회고성분석2011-10~2014-10래해원취진적56례절경후란소종류환자적초성진단자료。결과56례환자중71.4%(40/56)위량성종류,28.6%(16/56)위악성종류。량성조이낭성위주,현저고우악성조( P<0.01);재낭실성방면량자차이무통계학의의(P>0.05);재형태불규칙、실성、벽결구이상、내부혈류、복수화조력지수(RI)(<0.43)등지표성상도상악성조균고우량성조,차차이구유통계학의의(균P<0.05)。초성진단란소종류적부합솔위92.86%,령민도위97.37%,특이도위83.33%。결론초성능구쾌속、유효지감별출절경후부녀란소종류적성질,응당작위란소종류림상수선사사수단。
Objective To analyze the diagnostic value of ultrasound for postmenopausal women with ovarian neoplasm .Methods The data of ultrasound in 56 patients with ovarian neoplasm were collected from October 2011 to October 2014.Results In the 56 patients, 40 cases were diagnosed as having benign tumors (71.4%), 16 cases as having malignant tumors(28.6%).Cystic tumors were significantly higher in the benign group than those in the ma-lignant group ( P<0.01 ); The ultrasonic features of the malignant group in shape , solid, wall structure , internal blood flow, ascites, and RI(<0.43) were higher than those in the benign group (P<0.05).Compared with the pastoperative pathological diagnosis , the ultrasonic diagnosis had an accuracy of 92.86%, with the sensitive rate in 97.37%and speciality rate in 83.33%.Conclusion Ultrasound can quickly and effectively identify the nature of o-varian neoplasm in postmenopausal women and may be used as the preferred clinical screening for ovarian masses .